Improving IV Therapy Safety: Advanced Strategies & Innovations

Intravenous (IV) therapy, while essential for the delivery of medications, fluids, and nutrients directly into the bloodstream, carries inherent risks that can lead to significant patient harm and legal liabilities if not managed effectively. This article delves deeper into the advanced strategies and technological innovations necessary to mitigate these risks and improve IV therapy safety in healthcare settings.

Understanding Infiltration & Extravasation

Infiltration and extravasation represent two of the most significant complications associated with IV therapy, both stemming from issues related to the administration of IV fluids and medications.

• Infiltration occurs when IV fluids leak into surrounding tissues, usually due to improper cannula placement or dislodgement, which might occur due to patient movement or an incorrectly secured IV line. While infiltration can sometimes be relatively harmless, especially if the infiltrating fluid is non-irritating, it often causes discomfort and swelling at the infusion site.
• Extravasation presents a more severe complication and happens when vesicant substances—agents capable of causing blistering, severe tissue damage, and even necrosis—leak into the tissue surrounding the vein. Examples of vesicants include chemotherapeutic drugs, potassium solutions, antibiotics like vancomycin, and other medications known for their corrosive properties.

The risk of extravasation demands particular vigilance because the consequences can extend beyond simple discomfort, leading to long-term impairments, severe pain, and potential surgeries for tissue repair, which could result in permanent disability.

The Extent of IV Complications

In the United States, the financial and clinical impacts of IV complications are profound.

Nearly 200 million peripheral intravenous catheters and over 5 million central venous catheters are used annually in the United States. However, IV failure rates and complication incidence are as high as 53%, as referenced by “The Journal of the Association for Vascular Success.”

The National Library of Medicine states that rates for intravenous infiltration can exceed 16%, while the International Journal of Nursing Studies reports that catheter failures in individual studies were as high as 69%.

Furthermore, when comparing patients who experience complications with their peripheral intravenous lines to those who don’t, the differences are pretty striking.

Patients with IV complications tend to stay in the hospital longer on average—about six days compared to just under four days for those without issues. They also face heftier hospital bills, averaging nearly $11,000, while those without complications had bills around $7,000.

What’s more, the chances of going straight home after being discharged were lower for those with complications—only about 62% could do so, compared to nearly 78% of those who didn't have complications. Unfortunately, the risk of death was also higher for those with complications, at about 3.6%, compared to just 0.7% for those without.

The problem of IV complications is made worse because they’re often underreported or not reported at all. This makes it hard to understand how big the issue really is and to find solutions.

For instance, a study published in “BMJ Open Quality” illustrates the underreporting of IV complications in a neonatal intensive care unit. Initially, the baseline incidence rate of IV infiltrates was five per 1,000 line days. Following the development and implementation of an evidence-based guideline—which included enhanced surveillance, prevention, and management strategies, as well as educational programs for staff and a compliance checklist—the reported incidence rate of IV complications rose to nine per 1,000 line days post-intervention. This increase suggests an improvement in the detection of such complications.

Furthermore, the rate of severe Stage 4 infiltrates in the same unit significantly decreased during the post-intervention period, demonstrating the effectiveness of the guidelines and the checklist in managing and mitigating the most severe cases of infiltrates.

IV Therapy Safety: Strategies for Prevention & Management

Intravenous therapy requires stringent preventive and management strategies to ensure patient safety. Healthcare organizations should adopt a multifaceted approach that spans from enhanced clinical training to the integration of health IT innovations for IV insertions to improve IV therapy safety.

The following strategies aim to reduce the risks of serious complications like infiltration and extravasation and improve overall treatment outcomes. They include rigorous training programs, precise technology applications, robust procedural protocols, comprehensive incident reporting systems, and patient education initiatives. Each element is designed to elevate the standards of care and safeguard patient health during IV therapy.

Enhanced Clinical Training & Competency Assessments

• Scenario-Based Learning: Incorporate realistic, scenario-based training for all nursing staff that includes handling emergency responses to IV complications. This training should be a mix of digital simulations and live-action drills that mimic the pressures and demands of actual medical emergencies.
• Annual Competency Assessments: Establish a mandatory annual review and competency assessment for all staff involved in IV therapy to ensure skills remain sharp and up-to-date.

Utilization of Precision Technology for IV Insertions

• Ultrasound-Guided Catheter Placement: Promote the use of ultrasound technology to guide the insertion of catheters, particularly in patients with difficult venous access. This approach has been shown to reduce the risk of complications and improve IV therapy safety by allowing direct visualization of veins and needle placement. A study conducted by the Cleveland Clinic found that ultrasound guidance was utilized in nearly 58% of successful IV placement attempts. Furthermore, the American Nurse Association states that the ultrasound-guided insertion method performed by trained nurses can decrease the need for central venous catheter placement by as much as 80%.
• Smart Pumps and Sensors: Deploy smart infusion pumps equipped with pressure sensors and alarms that can detect early signs of pressure changes indicative of infiltration or extravasation. These devices should be programmable based on the type of medication and the patient’s specific characteristics.

Robust IV Therapy Protocols & Standardized Procedures

• IV Site Selection and Rotation Policies: Develop and enforce policies on optimal site selection and rotation to minimize the risk of vein irritation and damage. These guidelines should be specific to the type of infusion and the patient’s condition.
• Pre-Infusion Risk Assessments with Automated Checklists: Implement obligatory pre-infusion risk assessments that utilize automated checklists to systematically evaluate the patient’s history, vein quality, and medication type. This technology-driven approach ensures that all relevant factors are considered to tailor the infusion approach, thereby minimizing potential complications. Automated checklists help standardize the assessment process, reducing variability and ensuring a consistent, thorough evaluation before every infusion.

Utilization of Incident Reporting Software

• Real-Time Reporting Capabilities: Implement and utilize incident reporting software that enables real-time reporting and tracking of any IV-related incidents. This software should allow for immediate escalation of incidents to vascular access specialists or clinical supervisors.
• Data Analytics for Continuous Improvement: Leverage the data collected from incident reports to perform regular analytics. Use these insights to identify patterns, educate staff, and continually refine protocols.

Creation of Specialized Vascular Access Teams (VATs):

• Dedicated Specialists: Establish VATs comprised of specialists trained in advanced vascular access techniques. These teams should oversee complex IV insertions, conduct regular patient rounding to assess IV sites, and serve as a rapid response unit for any IV complications.
• Ongoing Education and Leadership: VATs should also lead in-service training sessions and disseminate updates on best practices and technological advancements in IV therapy.

Patient Education and Empowerment:

• Informative Materials and Pre-Treatment Briefings: Provide patients with detailed educational materials and pre-treatment briefings on the risks and signs of IV therapy complications. Encourage patients to report any discomfort, pain, or changes in the IV site immediately.
• Feedback Systems: Implement patient feedback systems dedicated to IV therapy experiences to gauge patient satisfaction and gather direct input on the quality of IV care provided.

Final Thoughts

The integration of advanced training, precision technologies, robust protocols, and patient engagement strategies significantly enhances IV therapy safety and efficacy.

By adopting these comprehensive approaches, healthcare providers can not only reduce the incidence of complications from IV therapy but also improve overall patient outcomes and satisfaction. As IV therapy continues to be a critical component of medical treatment, continuous innovation and adherence to best practices in IV safety will remain paramount.

Ready to Learn More?

Connect with our team to learn more about how our best-in-class incident management software helps organizations like yours minimize patient safety risks like IV therapy complications. Book a demo to get an in-depth look at our platform.